DOLLY VANCE Insider Trading $RIGL RIGEL PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOLLY VANCE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOLLY VANCE. DOLLY VANCE is EVP Corp. Affairs, G.C., Sect. in RIGEL PHARMACEUTICALS INC ($RIGL) and SVP, Gen. Counsel, Corp. Sec. in RIGEL PHARMACEUTICALS INC ($RIGL) and VP Intel. Prop.& Gen.Counsel in RIGEL PHARMACEUTICALS INC ($RIGL).
DOLLY VANCE in RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOLLY VANCE: EVP Corp. Affairs, G.C., Sect., SVP, Gen. Counsel, Corp. Sec., VP Intel. Prop.& Gen.Counsel
Holdings: 4,385 shares
Current Value: $10,743
Latest Transaction: Apr 02 2021
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DOLLY VANCE in RIGEL PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.42 | 37,500 | 90,750 | 37,500 | |
| Jan 29 2021 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 3.54 | 125,000 | 442,500 | 125,000 | |
| Feb 07 2020 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.42 | 150,000 | 363,000 | 150,000 | |
| Nov 20 2019 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 4.49 | 75,000 | 336,750 | 75,000 | |
| Mar 22 2019 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 4.49 | 75,000 | 336,750 | 75,000 | |
| Jan 25 2019 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.00 | 162,500 | 325,000 | 162,500 | |
| May 11 2018 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.11 | 150,000 | 316,500 | 150,000 | |
| Jan 26 2018 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 4.49 | 150,000 | 673,500 | 150,000 | |
| Apr 21 2017 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.74 | 150,000 | 411,000 | 150,000 | |
| Apr 21 2017 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 3.59 | 62,500 | 224,375 | 62,500 | |
| Feb 06 2017 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.11 | 150,000 | 316,500 | 150,000 | |
| Apr 06 2016 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
| Apr 06 2016 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 3.59 | 62,500 | 224,375 | 62,500 | |
| Jan 28 2016 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 2.74 | 150,000 | 411,000 | 150,000 | |
| Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
| Jun 01 2010 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | EVP Corp. Affairs, ... | Option Exercise | A | 6.55 | 67,000 | 438,850 | 67,000 | |
| Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 9.62 | 105,000 | 1,010,100 | 105,000 | |
| Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 6.49 | 100,000 | 649,000 | 100,000 | |
| Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 26.45 | 90,000 | 2,380,500 | 90,000 | |
| Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | SVP, Gen. Counsel, ... | Option Exercise | A | 11.73 | 103,788 | 1,217,433 | 103,788 | |
| Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 9.56 | 16,249 | 155,340 | 16,249 | |
| Jan 27 2006 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 7.40 | 45,000 | 333,000 | 45,000 | |
| Oct 06 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 24.56 | 80,000 | 1,964,800 | 80,000 | |
| May 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | M | 9.20 | 15,000 | 138,000 | 16,249 | |
| May 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Sell | S | 19.71 | 15,000 | 295,650 | 4,385 | 19.4 K to 4.4 K (-77.38 %) |
| May 10 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Buy | M | 9.20 | 15,000 | 138,000 | 19,385 | 4.4 K to 19.4 K (+342.08 %) |
| Mar 30 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Buy | P | 15.99 | 1,000 | 15,990 | 4,385 | 3.4 K to 4.4 K (+29.54 %) |
| Feb 01 2005 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 22.17 | 38,751 | 859,110 | 38,751 | |
| Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 17.66 | 45,000 | 794,700 | 45,000 |
Page: 1